NANCY PASCUA: Open Payments
NPI 1780702399 · VANCOUVER, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 25 payments from 6 companies in 2025. Trend: 2023 $250 · 2024 $504 · 2025 $894
Food & beverage: $837Education: $56
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $299 |
| Otsuka America Pharmaceutical, Inc. | 4 | $158 |
| Janssen Pharmaceuticals, Inc | 4 | $142 |
| E.R. Squibb & Sons, L.L.C. | 2 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $102 |
| Axsome Therapeutics, Inc. | 1 | $70 |
Products named: UZEDY, INVEGA SUSTENNA, CAPLYTA, REXULTI, ABILIFY ASIMTUFII, Auvelity, COBENFY, AUSTEDO XR.
Industry payments across WA — which companies pay providers there.
